MedTrace Logo

Effect of Adding Sildenafil to Protocol of Endometrial Preparation in Outcome of Frozen-thawed Embryo Transfer Cycles

NCT01668446 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2012-09-13

No results posted yet for this study

Summary

The target of this study was an estimate the result of sildenafil on ultrasonographic endometrial thickness, endometrial pattern investigation estrogen level on the day of progesterone administration, Implantation rate and chemical pregnancy rate in frozen embryo transfer cycles .

Conditions

  • Endometrial Preparation
  • Frozen Embryo Transfer

Interventions

DRUG

Sildenafil

sildenafil tablets(50 mg) daily

DRUG

estradiol valerat

Sponsors & Collaborators

  • Razieh dehghani firouzabadi

    collaborator UNKNOWN

  • Robab davar

    collaborator UNKNOWN

  • farzaneh hojjat

    lead OTHER

Principal Investigators

  • farzaneh hojjat, MD · Department of Obstetrics and Gynecology, Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Science, Bouali Ave. Safaieh, Yazd,Iran.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2009-09-30
Completion
2011-02-28

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01668446 on ClinicalTrials.gov